Abstract
Dapagliflozin (DAP) is a potent and selective sodium-glucose contransporter-2 inhibitor, for treating type 2 diabetes. DAP propanediol monohydrate (DA......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
